Recommendations For The Use Of Thromboprophylaxis In Hospitalized Patients With Covid-19 In Argentina

Fernando J Vazquez, Jorge Korin,Enrique M Baldessari,Federico J Capparelli,Paula Gutierrez,Carlos Pale,Florencia Bocanegra, Beatriz Grand,Diana Penchasky,María Mónica Gonzalez Alcántara,María Sol Prémoli,Aldo Tabares,Néstor Wainsztein,Diego Odetto,Carlos Vaccaro, Eleno Martínez Aquino,Olga Cumpian,Verónica Falabella, Santiago Antuel García,José Saadi,Mariana Siccardi,Esteban Gándara

MEDICINA-BUENOS AIRES（2020）

引用 0|浏览1

暂无评分

摘要

Although the incidence is uncertain, some case reports suggest that COVID 19 infection is associated with an increased risk of venous thromboembolism. We suggest starting prophylactic anticoagulant therapy for all patients hospitalized with a symptomatic infection with COVID-19, unless contraindicated, with enoxaparin 40 mg SC daily if creatinine clearance is greater than 30 ml/min.

查看译文

关键词

COVID-19, prophylaxis, venous thrombosis, pulmonary embolism, anticoagulant drugs, heparin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要